CLINICAL_TRIALS
trial_result
· 2010-03-15
Clinical Trial Update: PleuraSeal Post Market Study (Europe) [Phase 4]
Summary
A Phase 4 post-market study of PleuraSeal in Europe for patients undergoing pulmonary lobectomy has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Integra LifeSciences Corporation | Conditions: Lung Disease, Pulmonary Lobectomy | Phase 4 | Status: COMPLETED | Results posted: 2010-03-15